A Dosimetric Comparison of Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy in Patients Treated with Post-Mastectomy Radiotherapy.

Cancer conformity homogeneity mastectomy radiotherapy

Journal

European journal of breast health
ISSN: 2587-0831
Titre abrégé: Eur J Breast Health
Pays: Turkey
ID NLM: 101709357

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 16 09 2022
accepted: 14 12 2022
entrez: 6 1 2023
pubmed: 7 1 2023
medline: 7 1 2023
Statut: epublish

Résumé

Radiotherapy continues to play an important role in the management of breast cancer. This study compared the dosimetric differences between the techniques of intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in breast cancer patients who had radiotherapy after mastectomy. Forty post-mastectomy patients (19 right-sided breast and 21 left-sided breast) treated with the IMRT technique using 7-9 fields who were re-planned with VMAT using 2 coplanar arc on the Varian Vital beam linear accelerator between January, 2020 and August, 2021 were included in this study. The patients received 42 Gy in 15 fractions to the chest wall, lymph nodes and supraclavicular nodes. The dosimetric parameter for planning target volume (PTV), organs at risk (OAR) and the integral dose to the body were analysed. Student's t-test for two independent means was used to analyse the dosimetric differences between the plans. Clinical goals were achieved for both techniques. In terms of PTV coverage at 95% (IMRT: 712.17±233) vs (VMAT: 694.9±214) and the homogeneity index (IMRT: 0.075±0.04) vs (VMAT: 0.104±0.03), IMRT resulted in better dose coverage and homogeneity than VMAT. However, with the conformity index, no significant difference was seen. As regards the OARs, the mean doses, V With IMRT, better PTV coverage, homogeneity and OAR sparing were observed. Additionally, VMAT resulted in a lower delivery time than IMRT. Overall, both techniques offered dosimetric qualities that were clinically acceptable.

Identifiants

pubmed: 36605476
doi: 10.4274/ejbh.galenos.2022.2022-9-2
pii: 57741
pmc: PMC9806941
doi:

Types de publication

Journal Article

Langues

eng

Pagination

92-98

Informations de copyright

©Copyright 2023 by the the Turkish Federation of Breast Diseases Societies / European Journal of Breast Health published by Galenos Publishing House.

Déclaration de conflit d'intérêts

Conflict of Interest: No conflict of interest was declared by the authors.

Références

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):224-33
pubmed: 23102695
Radiat Oncol. 2015 Nov 17;10:231
pubmed: 26577189
Strahlenther Onkol. 2013 May;189(5):380-6
pubmed: 23525513
Acta Oncol. 2009;48(4):495-503
pubmed: 19169915
J Res Med Sci. 2013 May;18(5):413-6
pubmed: 24174948
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):1-7
pubmed: 16618572
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1231-9
pubmed: 8262852
Eur J Breast Health. 2021 Jun 24;17(3):247-252
pubmed: 34263152
Radiat Oncol. 2011 Jun 08;6:67
pubmed: 21651799
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1238-50
pubmed: 17512134
Medicine (Baltimore). 2016 Apr;95(14):e3295
pubmed: 27057896
Sci Rep. 2015 Jul 21;5:12274
pubmed: 26194593
Med Phys. 2003 Aug;30(8):2065-71
pubmed: 12945972
Strahlenther Onkol. 2012 Jan;188(1):97-9
pubmed: 22234506
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):672-82
pubmed: 15939548
Radiol Oncol. 2015 Mar 03;49(1):91-8
pubmed: 25810708
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1505-11
pubmed: 17674981
Radiat Oncol. 2018 Sep 24;13(1):187
pubmed: 30249274
Acta Oncol. 2012 Mar;51(3):333-44
pubmed: 22171587

Auteurs

Samuel Adeneye (S)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Michael Akpochafor (M)

Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Nusirat Adedewe (N)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Muhammad Habeebu (M)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Ramotallah Jubril (R)

Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Abe Adebayo (A)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Omolola Salako (O)

Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Adedayo Joseph (A)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Inioluwa Ariyo (I)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Eseoghene Awhariado (E)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Rasak Lawal (R)

NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria.

Classifications MeSH